- Our Services
-
Patients and Families
- Get Directions
- Parking
- Childrens Locations
- Getting Around
- Guidelines for Visitors
- Contact a Patient
- Contact Children's
- Send an e-Card
- Gift Shop
Planning a Visit
- Find a Doctor
- Make an Appointment
- Child Health A-Z
- Community Ed.Classes
- Injury Prevention
- International Patients
- Medical Records
- Patient Handbook
- Patient Procedures
Parents
- For Health Professionals
- Research
- Ways to Give
- News
Research
Plasma Response During Organ Failure
Patient Plasma Response and Outcome in Septic Shock With Thrombocytopenia Associated Multiple Organ Failure in Children
Protocol Description
The purpose of this multi-center study is to learn how blood-clotting substances respond in children with septic shock, low platelet counts (thrombocytopenia), and multiple organ failure when a plasma-exchange protocol is applied in treatment. A preliminary study performed at Children's Hospital of Pittsburgh of UPMC suggested significant improvement in organ system dysfunction in thrombocytopenia-associated multiple organ failure patients when a plasma-exchange protocol was used, compared to standard therapy alone. Understanding the impact of plasma exchange on blood will help clinicians to diagnose and treat serious infections in children.
Eligibility Criteria
Pediatric Intensive Care Unit (PICU) patients with thrombocytopenia and multiple organ failure who are scheduled to undergo plasma exchange will be considered for this study, subject to other screening criteria.
Boys: All ages
Girls: All ages
Requirements
While patient undergoes plasma exchange in the PICU, researchers will take small blood samples via the patient’s intravenous line on days 1, 2, 4, 8, 15 and 28 to measure levels of certain substances within the blood to determine if the exchange is beneficial.
Visits: Occurs during hospitalization
Duration: Up to 28 days
Status: Open for Enrollment
Source of Support
Children’s Hospital of Pittsburgh of UPMC
Children’s Hospital of Atlanta Foundation
Additional Resources
Study Description at National Institutes of Health
Primary Investigator(s)
Rajesh Aneja, MD
Contact Information
To get started, please contact:
Rajesh Aneja, MD
412-692-7366
Last Update
September 25, 2008
September 25, 2008

Expert in Pediatric Rehabilitation Medicine Appointed Chief
Study of Peptide Vaccines in Children with Gliomas
Study Finds Effective Tool in Preventing Teen Dating Violence